tiprankstipranks
Silo Pharma (SILO)
NASDAQ:SILO
US Market

Silo Pharma (SILO) Financial Statements

Compare
217 Followers

Silo Pharma Financial Overview

Silo Pharma's market cap is currently $4.53M. The company's EPS TTM is $-1.137; its P/E ratio is -0.67; Silo Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 72.10K$ 72.10K$ 72.10K$ 72.10K$ 71.26K
Gross Profit$ -813.96K$ 66.26K$ 66.26K$ 66.26K$ 66.26K
Operating Income$ -4.28M$ -4.71M$ -3.86M$ -3.63M$ -2.74M
EBITDA$ -4.28M$ -4.38M$ -3.63M$ -3.91M$ 4.19M
Net Income$ -4.23M$ -4.39M$ -3.70M$ -3.91M$ 3.90M
Balance Sheet
Cash & Short-Term Investments$ 6.86M$ 7.08M$ 7.67M$ 11.37M$ 10.26M
Total Assets$ 217.38K$ 7.41M$ 7.75M$ 11.64M$ 10.49M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -4.75M$ -3.91M$ -3.52M$ -11.37M$ -9.84M
Total Liabilities$ 1.30M$ 2.38M$ 1.57M$ 1.30M$ 1.43M
Stockholders' Equity$ 6.31M$ 5.03M$ 6.18M$ 10.34M$ 9.06M
Cash Flow
Free Cash Flow$ -4.66M$ -3.83M$ -3.22M$ -3.50M$ -2.28M
Operating Cash Flow$ -4.66M$ -3.83M$ -3.22M$ -3.50M$ -2.28M
Investing Cash Flow$ 644.02K$ 973.78K$ -4.15M$ 86.71K$ 7.19M
Financing Cash Flow$ 4.86M$ 3.24M$ -471.12K$ 4.94M$ 3.79M
Currency in USD

Silo Pharma Earnings and Revenue History

Silo Pharma Debt to Assets

Silo Pharma Cash Flow

Silo Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.